Patrick Baeuerle

Person

Munchen, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Constrained conditionally activated binding proteins
- Patent number 12,128,102
- Issue date Oct 29, 2024
- Takeda Pharmaceutical Company Limited
- Patrick Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Trispecific binding proteins and methods of use
- Patent number 12,084,518
- Issue date Sep 10, 2024
- HARPOON THERAPEUTICS, INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,981,716
- Issue date May 14, 2024
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 11,965,012
- Issue date Apr 23, 2024
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 11,851,491
- Issue date Dec 26, 2023
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bispecific-Fc molecules
- Patent number 11,753,475
- Issue date Sep 12, 2023
- Amgen Inc.
- Luis G. Borges
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,535,658
- Issue date Dec 27, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin 12 polypeptides and methods of use thereof
- Patent number 11,453,710
- Issue date Sep 27, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 11,377,638
- Issue date Jul 5, 2022
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,352,403
- Issue date Jun 7, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 11,242,376
- Issue date Feb 8, 2022
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Means and methods for the treament of B cell non-hodgkin lymphoma a...
- Patent number 11,154,617
- Issue date Oct 26, 2021
- Amgen Research (Munich) GmbH
- Patrick Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 11,085,021
- Issue date Aug 10, 2021
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 11,028,142
- Issue date Jun 8, 2021
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Trispecific binding proteins and methods of use
- Patent number 10,954,311
- Issue date Mar 23, 2021
- HARPOON THERAPEUTICS, INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prostate specific membrane antigen binding protein
- Patent number 10,849,973
- Issue date Dec 1, 2020
- HARPOON THERAPEUTICS, INC.
- Robert Dubridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PSMA targeting trispecific proteins and methods of use
- Patent number 10,844,134
- Issue date Nov 24, 2020
- HARPOON THERAPEUTICS, INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin-2 polypeptides
- Patent number 10,696,724
- Issue date Jun 30, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable interleukin 12 polypeptides
- Patent number 10,696,723
- Issue date Jun 30, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions comprising polypeptides
- Patent number 10,000,574
- Issue date Jun 19, 2018
- Amgen Research (Munich) GmbH
- Robert Hofmeister
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Trispecific binding proteins and methods of use
- Patent number 9,708,412
- Issue date Jul 18, 2017
- HARPOON THERAPEUTICS, INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dosage regimen for administering a CD19XCD3 bispecific antibody
- Patent number 8,840,888
- Issue date Sep 23, 2014
- Micromet AG
- Dirk Nagorsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Means and methods for the treatment of tumorous diseases
- Patent number 8,007,796
- Issue date Aug 30, 2011
- Micromet AG
- Patrick Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical composition comprising a bispecific antibody for EpCAM
- Patent number 7,919,089
- Issue date Apr 5, 2011
- Micromet AG
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition for the elimination of autoreactive B-cells
- Patent number 7,332,168
- Issue date Feb 19, 2008
- Micromet AG
- Marcel Zocher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
De-immunized MOG (poly)peptide constructs
- Patent number 7,323,440
- Issue date Jan 29, 2008
- Micromet AG
- Marcel Zocher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies
- Patent number 7,235,641
- Issue date Jun 26, 2007
- Micromet AG
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monitoring of gene expression by detecting hybridization to nucleic...
- Patent number 6,232,068
- Issue date May 15, 2001
- Rosetta Inpharmatics, Inc.
- Peter S. Linsley
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20240301026
- Publication date Sep 12, 2024
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR AUTOIMMUNITY REGULATION
- Publication number 20230338421
- Publication date Oct 26, 2023
- TCR2 Therapeutics Inc.
- Daniel GETTS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20230235010
- Publication date Jul 27, 2023
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC FC MOLECULES
- Publication number 20230212297
- Publication date Jul 6, 2023
- Amgen Inc.
- Luis G. Borges
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEASE-ACTIVATABLE BISPECIFIC PROTEINS
- Publication number 20230212318
- Publication date Jul 6, 2023
- Amgen Inc.
- Wei Yan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR GAMMA DELTA TCR REPROGRAMMING USING FU...
- Publication number 20230069322
- Publication date Mar 2, 2023
- TCR2 Therapeutics Inc.
- Jian DING
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20220362295
- Publication date Nov 17, 2022
- TCR2 Therapeutics Inc.
- Philippe KIEFFER-KWON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20220324930
- Publication date Oct 13, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20220298478
- Publication date Sep 22, 2022
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20220056096
- Publication date Feb 24, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20210403524
- Publication date Dec 30, 2021
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20210361704
- Publication date Nov 25, 2021
- TCR2 Therapeutics Inc.
- Patrick Alexander BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING TARGET SPECIFI...
- Publication number 20210315933
- Publication date Oct 14, 2021
- TCR2 Therapeutics Inc.
- Patrick Alexander Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20210253666
- Publication date Aug 19, 2021
- TCR2 Therapeutics Inc.
- Patrick Alexander Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20210206827
- Publication date Jul 8, 2021
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED T CELLS FOR THE TREATMENT OF CANCER
- Publication number 20210187022
- Publication date Jun 24, 2021
- TCR2 Therapeutics Inc.
- Daniel GETTS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRISPECIFIC BINDING PROTEINS AND METHODS OF USE
- Publication number 20210179735
- Publication date Jun 17, 2021
- Harpoon Therapeutics, Inc.
- Patrick BAEUERLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROSTATE SPECIFIC MEMBRANE ANTIGEN BINDING PROTEIN
- Publication number 20210100902
- Publication date Apr 8, 2021
- Harpoon Therapeutics, Inc.
- Robert DUBRIDGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA Targeting Trispecific Proteins and Methods of Use
- Publication number 20210095047
- Publication date Apr 1, 2021
- Harpoon Therapeutics, Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20210079057
- Publication date Mar 18, 2021
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20200362011
- Publication date Nov 19, 2020
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20200362306
- Publication date Nov 19, 2020
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20200283490
- Publication date Sep 10, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20200283489
- Publication date Sep 10, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20200040052
- Publication date Feb 6, 2020
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20190367576
- Publication date Dec 5, 2019
- Werewolf Therapeutics, Inc.
- William WINSTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20190276540
- Publication date Sep 12, 2019
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20190256571
- Publication date Aug 22, 2019
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INNATE IMMUNE CELL TRISPECIFIC BINDING PROTEINS AND METHODS OF USE
- Publication number 20190225702
- Publication date Jul 25, 2019
- Harpoon Therapeutics, Inc.
- Patrick BAEUERLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20190177694
- Publication date Jun 13, 2019
- TCR2 Therapeutics Inc.
- Patrick BAEUERLE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patrick Baeuerle

Person

Patents Grantslast 30 patents

Constrained conditionally activated binding proteins

Trispecific binding proteins and methods of use

Activatable interleukin-2 polypeptides and methods of use thereof

Compositions and methods for TCR reprogramming using fusion proteins

Compositions and methods for TCR reprogramming using fusion proteins

Bispecific-Fc molecules

Activatable interleukin-2 polypeptides and methods of use thereof

Activatable interleukin 12 polypeptides and methods of use thereof

Compositions and methods for TCR reprogramming using fusion proteins

Activatable interleukin-2 polypeptides and methods of use thereof

Compositions and methods for TCR reprogramming using fusion proteins

Means and methods for the treament of B cell non-hodgkin lymphoma a...

Compositions and methods for TCR reprogramming using fusion proteins

Compositions and methods for TCR reprogramming using fusion proteins

Trispecific binding proteins and methods of use

Prostate specific membrane antigen binding protein

PSMA targeting trispecific proteins and methods of use

Activatable interleukin-2 polypeptides

Activatable interleukin 12 polypeptides

Compositions comprising polypeptides

Trispecific binding proteins and methods of use

Dosage regimen for administering a CD19XCD3 bispecific antibody

Means and methods for the treatment of tumorous diseases

Pharmaceutical composition comprising a bispecific antibody for EpCAM

Composition for the elimination of autoreactive B-cells

De-immunized MOG (poly)peptide constructs

Bispecific antibodies

Monitoring of gene expression by detecting hybridization to nucleic...

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR AUTOIMMUNITY REGULATION

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

BISPECIFIC FC MOLECULES

PROTEASE-ACTIVATABLE BISPECIFIC PROTEINS

COMPOSITIONS AND METHODS FOR GAMMA DELTA TCR REPROGRAMMING USING FU...

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING TARGET SPECIFI...

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

ENGINEERED T CELLS FOR THE TREATMENT OF CANCER

TRISPECIFIC BINDING PROTEINS AND METHODS OF USE

PROSTATE SPECIFIC MEMBRANE ANTIGEN BINDING PROTEIN

PSMA Targeting Trispecific Proteins and Methods of Use

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

INNATE IMMUNE CELL TRISPECIFIC BINDING PROTEINS AND METHODS OF USE

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS